A phase 2 trial of Amlitelimab for the treatment of scleroderma
Latest Information Update: 12 Mar 2024
At a glance
- Drugs Amlitelimab (Primary)
- Indications Scleroderma
- Focus Therapeutic Use
- 12 Mar 2024 New trial record
- 11 Mar 2024 According to a Sanofi media release, initiation of this study expected by year-end.